DupCheck+ Highlights MBL Health’s Commitment to Addressing Critical Challenges in Clinical Trial Recruitment
Dubai, United Arab Emirates, 12th Feb 2025 — MBL Health is proud to announce the launch of DupCheck+, an innovative tool designed to streamline patient management in clinical trials by addressing the persistent issue of duplicate patient registrations. DupCheck+ is particularly critical in rare disease clinical trials, where every patient counts.
Duplicate patient records have long posed challenges in clinical trials, leading to inefficiencies, increased costs, and compromised data quality. This issue is especially pronounced in rare disease studies, where small patient populations demand the utmost precision and efficient resource utilization.
DupCheck+ offers a simple yet transformative solution, ensuring accurate and efficient data management while enhancing operational workflows for clinical trials, including those in the rare disease space.
“At MBL Health, we are committed to addressing the critical pain points in clinical trials, especially in rare disease research, where the stakes are exceptionally high,” said Masood Sahibzada, Founder of MBL Health. “ DupCheck+ represents our vision of simplifying processes while maintaining the highest standards of accuracy and efficiency.”
For more information about DupCheck+, visit https://mblhealth.co.uk/dupcheck/.
For media inquiries, please contact Anurag Garg at anuggg23@gmail.com
About MBL Health
MBL Health is a leading digital health tech company focused on creating innovative solutions to redefine patient care and streamline clinical trials. With a mission to tackle real-world challenges, MBL Health continues to develop products that deliver value to the healthcare industry, with a particular emphasis on enabling advancements in rare disease research
Media Contact
Organization: MBL Health
Contact Person: Anurag Garg
Website: https://mblhealth.co.uk/dupcheck/
Email: Send Email
City: Dubai
Country:United Arab Emirates
Release id:23700
